Is Omega Healthcare Investors (OHI) Outperforming Other Finance Stocks This Year?

OHI

Investors interested in Finance stocks should always be looking to find the best-performing companies in the group. Is Omega Healthcare Investors (OHI - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Finance peers, we might be able to answer that question.

Omega Healthcare Investors is a member of the Finance sector. This group includes 854 individual stocks and currently holds a Zacks Sector Rank of #13. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. OHI is currently sporting a Zacks Rank of #2 (Buy).

Over the past three months, the Zacks Consensus Estimate for OHI's full-year earnings has moved 1.18% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.

Our latest available data shows that OHI has returned about 9.76% since the start of the calendar year. Meanwhile, stocks in the Finance group have gained about 6.87% on average. This means that Omega Healthcare Investors is outperforming the sector as a whole this year.

Looking more specifically, OHI belongs to the REIT and Equity Trust - Other industry, which includes 121 individual stocks and currently sits at #97 in the Zacks Industry Rank. On average, this group has gained an average of 6.33% so far this year, meaning that OHI is performing better in terms of year-to-date returns.

Investors in the Finance sector will want to keep a close eye on OHI as it attempts to continue its solid performance.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>